The Future Urologic Oncologists program, @UroOnc will take place, July 24-26 in Indianapolis.
PGY2/3s, learn from the exec board + members what the SUO provides; fellowship, community, leadership opportunities + friendships.
Sign up soon. App deadline is approaching.
Huge Thank You to @IUuro for hosting me as a Uro Onc visiting fellow! Incredible week learning from @ClintCaryMD and Dr Tim Masterson - shadowing surgeries, clinic, and conferences
Made possible by @SUO_YUO Visiting Fellow Grant Program
@FCUroOnc
@DrSpratticus I don’t understand where this 1 in 3 w/ testosterone deficiency is coming from. Sources cited in article show transient, minor drop in T in (still well in eugonadal range; and some hypo pre op improved post-RALP). Certainly not enough to account for undetectable PSA.
🧵regarding Lord of the Rings - related traumatic injuries, and whether access to modern Level 1 trauma centers could have decreased morbidity and mortality within the Fellowship.
Here we will take a more evidence-based approach to some of the injuries in Middle Earth
(1/ )
Surgery is a "wicked" environment: feedback is delayed, noisy, and often biased. My essay on why experience doesn't always equal mastery, and how to learn when the feedback loops are broken.
https://t.co/mkHMtpskBV
#MedTwitter#Surgery#MedEd
.@FedGhali - was so great to have you at the @FoxChaseCancer / @FCUroOnc!
Fantastic talk - fresh and provocative ideas from a critical and creative thinker!
What does gender-affirming care look like in everyday urologic practice? @ercwltn and @_KochDoc discuss the evolving landscape of gender-affirming care, barriers to access, and training pathways #URO284@OSU_Urology@SocietyGURS
https://t.co/iz1zgwiEjb
So special to host @SBoorjian, Chair of @MayoUrology, as the Judith & Thomas Leidy Visiting Professor.
One of the greatest minds in urology with deep historic and personal ties to @FCUroOnc.
Have learned so much from Steve over the years - this visit was no exception!
@MaxKates An interesting pool of potential reviewers with enough experience to provide a quality review but enough financial motivation to review for a low fee: SUO Fellows! Sign me up.
Very substantial reduction in mortality despite screening too late, too high a threshold, nonattendance in intervention arm, contamination in control arm, diagnosing too much low-grade dz, marginal dx/tx quality, and other issues. & NND 12 compares well to anything in prevention!
Huge Thank You to @rezanab for coming up from @DukeUrology to present today at @FCUroOnc Grand Rounds, giving an incredible lecture on IVC tumor thrombectomy.
Proud to have learned from him @emory_urology and now to see him doing such huge things in practice.
Tonight we had the honor of celebrating @dytcmd ‘s endowment!
It was surreal to be back at this great institution after a decade and hang out with old friends @UROncDoc ! Thanks @uretericbud for organizing the events. @benristau@UroCorrea@FCUroOnc